Additive Homeopathy in Cancer Patients
Additive Homeopathy in Cancer Patients
The investigators aim to investigate the validity of their previous results in a randomized
 prospective, placebo-controlled, double-blind, multicenter controlled evaluation of
 questionnaires in patients with advanced malignant tumors. The investigators plan to compare
 the treatment outcome (quality of life and survival) in tumor patients, receiving standard or
 "add-on" homeopathic treatment.

 The null hypothesis is that "add-on" homeopathic treatment does not create a benefit for
 cancer patients. In addition the investigators evaluate survival time.
The EORTC-QLQ-C30 as well as a VAS scale for subjective well-being will be filled out by the
 patients.
Inclusion Criteria:

 -  Informed consent

 -  Clinical diagnosis of advanced tumor stages of glioblastoma IV, metastasized sarcoma,
 as well as non small-cell lung carcinoma (NSCLC) IV.

 Exclusion Criteria:

 -  Pregnant patients